F023 Psychocutaneous Disease: Treating the Difficult Patient
DESCRIPTION
Common psychocutaneous diseases include delusional infestation (delusions of parasitosis), skin picking disorder and other body-focused and repetitive behaviors, and body dysmorphic disorder (BDD). Affected individuals routinely refuse a psychiatric referral, placing the burden of care primarily on dermatologists. This session will focus on effectively managing such conditions in complex adult and pediatric patients by utilizing effective drugs and psychotherapies, as well as implementing stress reduction interventions. Speakers will also address skin conditions with secondary mental illness, screening for BDD, and navigating patients with difficult personalities in the dermatology setting.
LEARNING OBJECTIVES
Describe common psychocutaneous diseases in adults and children and confidently identify the associated psychiatric/psychosocial comorbidities.
Discuss skin diseases associated with mental illness and the approach to the patient with a personality or body dysmorphic disorder in the dermatology setting.
Develop appropriate management plans for the challenging patient with a psychocutaneous disease by utilizing effective drugs and psychotherapies and implementing stress reduction interventions.
SCHEDULE
9:00 AM
International classification of psychodermatologic disorders
Ladan Mostaghimi, MD
9:06 AM
A rose by any other name: the approach to the patient with delusional infestation
Jenny Eileen Murase, MD, FAAD
9:18 AM
Skin picking disorder and other body-focused repetitive behaviors: current and emerging therapies
Katlein Franca, MD, MSc, PhD
9:30 AM
Psychiatric and psychological aspects of inflammatory skin and hair diseases
Maria-Angeliki Gkini
9:42 AM
Psychopharmacology in dermatology
John Y. M. Koo, MD, FAAD
9:54 AM
Q&A
Katlein Franca, MD, MSc, PhD, Maria-Angeliki Gkini, John Y. M. Koo, MD, FAAD, Ladan Mostaghimi, MD, Jenny Eileen Murase, MD, FAAD
10:06 AM
Dissatisfaction with aesthetic procedures: the 'Zoom effect' and implementing screening for body dysmorphic disorder
George Kroumpouzos, MD, PhD, FAAD
10:18 AM
Navigating patients with difficult personalities
Mio Nakamura, MD, MS, FAAD
10:30 AM
Pediatric psychodermatology and promoting psychosocial health
Margaret S. Lee, MD, PhD, FAAD
10:42 AM
Optimizing skin health: strategies to reduce stress
Keira L. Barr, MD, FAAD
10:54 AM
Q&A
George Kroumpouzos, MD, PhD, FAAD, Keira L. Barr, MD, FAAD, Margaret S. Lee, MD, PhD, FAAD, Mio Nakamura, MD, MS, FAAD
DIRECTOR
George Kroumpouzos, MD, PhD, FAAD
SPEAKERS
Keira L. Barr, MD, FAAD
Katlein Franca, MD, MSc, PhD
Maria-Angeliki Gkini
John Y. M. Koo, MD, FAAD
Margaret S. Lee, MD, PhD, FAAD
Ladan Mostaghimi, MD
Jenny Eileen Murase, MD, FAAD
Mio Nakamura, MD, MS, FAAD
HANDOUTS
DISCLOSURES
Keira L. Barr, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees); FemHealth – Advisory Board(Stock Options); K'ept Health – Advisory Board(Stock Options); LearnHealth/LearnSkin – Advisory Board(Stock Options), Speaker/Faculty Education(Fees); Sanofi – Consultant (1099 relationship)(Fees);
Katlein Franca, MD, MSc, PhD
Health.com – Advisory Board(Honoraria); Springer Publishing – Other(Other Financial Benefit); Verywell Health – Advisory Board(Fees); Wiley-Blackwell – Other(Other Financial Benefit);
Maria-Angeliki Gkini
AbbVie – Advisory Board(Fees), Investigator(Grants/Research Funding), Other(Honoraria), Speaker(Fees); Almirall – Speaker(Fees); Amgen – Investigator(Grants/Research Funding); Argenx – Investigator(Grants/Research Funding); Bristol Myers Squibb – Speaker(Fees); European Academy of Dermatology and Venereology – Other(No Compensation Received); Faran SA – Other(Honoraria); FREZYDERM – Other(Honoraria); Galderma – Advisory Board(Fees), Other(Honoraria), Speaker/Faculty Education(Fees); Hair+Me – Consultant (1099 relationship)(Fees); Incyte – Investigator(Grants/Research Funding); janssen – Other(Honoraria); Janssen-Cilag – Advisory Board(Fees), Investigator(Grants/Research Funding), Speaker/Faculty Education(Fees); L'Oreal UK & Ireland – Speaker(Fees); Leo Pharma – Investigator(Grants/Research Funding), Speaker(Fees); Novartis – Other(Honoraria), Speaker(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Pharmaserv Lilly – Other(Honoraria), Speaker(Fees); Soterios Pharma – Investigator(Fees), Other(Honoraria); UCB – Advisory Board(Fees), Other(Honoraria), Speaker(Fees);
John Y. M. Koo, MD, FAAD
AbbVie – Speaker(Honoraria); Amgen – Advisory Board(Honoraria), Speaker(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); Bristol-Myers Squibb – Speaker(Honoraria); Dermavant Sciences, Inc. – Speaker(Honoraria); Eli Lilly and Company – Speaker(Honoraria); Galderma – Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Speaker(Honoraria); Leo Pharma Inc. – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Speaker(Fees); Regeneron – Speaker(Honoraria); Sanofi – Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria), Speaker(Honoraria); UCB – Speaker(Honoraria);
George Kroumpouzos, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Margaret S. Lee, MD, PhD, FAAD
Pfizer Inc. – Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Consultant (1099 relationship)(Honoraria);
Ladan Mostaghimi, MD
Pfizer Inc. – Consultant (1099 relationship)(Honoraria);
Jenny Eileen Murase, MD, FAAD
AbbVie – Consultant(Honoraria), Speaker/Faculty Education(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); Attovia Therapeutics – Consultant (1099 relationship)(Honoraria); Blueprint Medicines – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Eli Lilly – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker/Faculty Education(Honoraria); Galderma – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Leo Pharma – Advisory Board(Honoraria); Leo Pharma Inc – Speaker/Faculty Education(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Regeneron – Speaker/Faculty Education(Honoraria); Sanofi – Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); UCB – Advisory Board(Honoraria), Consultant(Honoraria), Speaker/Faculty Education(Honoraria); UpToDate – Consultant(Honoraria);
Mio Nakamura, MD, MS, FAAD
Amgen – Investigator(Grants/Research Funding); argenx – Advisory Board(Honoraria), Investigator(Grants/Research Funding); AstraZeneca – Investigator(Grants/Research Funding); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Galderma – Investigator(Grants/Research Funding); janssen – Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Sol-Gel Technologies – Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding);